Safety evaluation of FM101, an A3 adenosine receptor modulator, in rat, for developing as therapeutics of glaucoma and hepatitis.

Park, Chong-Woo; Han, Chung-Tack; Sakaguchi, Yasue; Lee, Jiyoun; Youn, Hwa-Young

Park, Chong-Woo; Han, Chung-Tack; Sakaguchi, Yasue; Lee, Jiyoun; Youn, Hwa-Young.

Afiliação

Park CW; R&D Center, Futuremedicine Co., Ltd., Seongnam, Republic of Korea.
Han CT; Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Sakaguchi Y; Biotoxtech Co., Ltd., Cheongju, Republic of Korea.
Lee J; Ina Research Inc., Ina, Japan.
Youn HY; R&D Center, Futuremedicine Co., Ltd., Seongnam, Republic of Korea.

EXCLI J ; 19: 187-200, 2020.

Article em En | MEDLINE | ID: mdl-32256265

Palavras-chave

28-day subchronic toxicity; A3AR modulator; acute oral toxicity; adenosine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article